BRCA1 185delAG mutation inhibits Akt-dependent, IAP-mediated caspase 3 inactivation in human ovarian surface epithelial cells

Experimental Cell Research

Volumn 298, Issue 1, 2004, Pages 9-16

  Johnson, Nicole C ^a   Dan, Han C ^a   Cheng, Jin Q ^a   Kruk, Patricia A ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Akt; Apoptosis; BRCA1; Caspase 3; Hereditary ovarian cancer; XIAP

Indexed keywords

BRCA1 PROTEIN; CASPASE 3; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN KINASE B; X LINKED INHIBITOR OF APOPTOSIS;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; EPITHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

EID: 3042743886     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.04.003     Document Type: Article

References (33)

1. Cryns V., Yuan J. Proteases to die for. Genes Dev. 12:1998;1551-1570
2. Johnson A.L., Bridgham J.T. Caspase-mediated apoptosis in the vertebrate ovary. Reproduction. 24:2002;19-27
3. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9257-9360
4. Wolf B.B., Schuler M., Escheverri D., Green D.R. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase activation. J. Biol. Chem. 274:1999;30651-30656
5. Hercez W., Wang Z. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol. Cell. Biol. 7:1999;5124-5133
6. Yang Y.L., Li X.M. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res. 10:2000;169-177
7. Holcik M., Gibson H., Korneluk H.R.G. XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 6:2001;253-261
8. Huang H., Joazeiro C.A.P., Bonfoco E., Kamada S., Leverson J.D., Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspase 3 and 7. J. Biol. Chem. 275:2000;26661-26664
9. Gagnon V., St-Germain M.E., Parent S., Asselin E. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1. Int. J. Oncol. 23:2003;803-810
10. Dan H.C., Sun M., Kaneko S., Feldman R.I., Nicosia S.V., Wang H.G., Tsang B.K., Cheng J.Q. Akt phosphorylation and stabilization of XIAP. J. Biol. Chem. 279:2004;5405-5412
11. Deng C., Brodie S.G. Roles of BRCA1 and its interacting proteins. BioEssays. 22:2000;728-737
12. Thangaraju M., Kaufmann S.H., Couch F.J. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J. Biol. Chem. 275:2000;33487-33496
13. Ludwig T., Fisher P., Ganesan S., Efstratiadis A. Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev. 15:2001;1188-1193
14. Ben David Y., Chetrit A., Hirsh-Yechezkel G., Friedman E., Beck B.D., Beller U., Ben-Baruch G., Fishman A., Levavi H., Lubin F., Menczer J., Piura B., Struewing J.P., Modan B. Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J. Clin. Oncol. 20:2002;463-466
15. Rubin S.C., Benjamin I., Behbekht K., Takahashi H., Morgan M.A., LiVolsi V.A., Berchuck A., Muto M.G., Garber J.E., Weber B.L., Lynch H.T., Boyd J. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N. Engl. J. Med. 335:1996;1416
16. Diez O., Domenech M., Alonso M.C., Brunet J., Sanz J., Cortes J., del Rio E., Baiget M. Identification of the 185delAG BRCA1 mutation in a Spanish gypsy population. Hum. Genet. 103:1998;707-708
17. Mullineaux L.G., Castellano T.M., Shaw J., Axell L., Wood M.E., Diab S., Klein C., Sitarik M., Deffenbaugh A.M., Graw S.L. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer. 98:2003;597-602
18. Ford D., Easton D.F., Bishop D.T., Narod S.A., Goldgar D.E. The Breast Cancer Linkage Consortium Risks of cancer in BRCA1 mutation carriers. Lancet. 343:1994;692-695
19. Frank T.S., Manley S.A., Olopade O.I., Cummings S., Garber J.E., Bernhardt B., Antman K., Russo D., Wood M.E., Mullineau L., Isaacs C., Peshkin B., Buys S., Venne V., Rowley P.T., Loader S., Offit K., Robson M., Hampel H., Brener D., Winer E.P., Clark S., Weber B., Strong L.C., Thomas A. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J. Clin. Oncol. 16:1998;2417-2425
20. Johnson N.C., Kruk P.A. BRCA1 zinc RING finger domain disruption alters caspase response in ovarian surface epithelial cells. Cancer Cell Int. 2(7):2002;1-8
21. Johannsson O.T., Ranstam J., Borh A., Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J. Clin. Oncol. 16:1998;397-404
22. Maines-Bandiera S.L., Kruk P.A., Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am. J. Obstet. Gynecol. 167:1992;729-735
23. Alfonso-De Matte M.Y., Yang H., Evans M.S., Cheng J.Q., Kruk P.A. Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells. Cancer Res. 62:2002;4575-4578
24. Cheng J.Q., Jiang X., Fraser M., Li M., Dan H.C., Sun M., Tsang B.K. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resist. Updat. 5:2002;131-146
25. Liao W., Yeung S.C., Chan L. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum. J. Biol. Chem. 273:1998;27225-27230
26. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P.K., Norris F.H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J.C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A., Skolnick M.H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71
27. Sun C., Cai M., Gunasekera A.H., Meadows R.P., Wang H., Chen J., Zhang H., Wu W., Xu H., Ng S., Fesik S.W. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature. 401:1999;818-821
28. Bossy-Wetzel E., Green D.R. Apoptosis: checkpoint at the mitochondrial frontier. Mutat. Res. 434:1999;243-251
29. Wei Y., Fox T., Chambers S.P., Sintchak J., Coll J.T., Golec J.M., Swenson L., Wilson K.P., Charifson P.S. The structures of caspases-1, -3, -7 and-8 reveal the basis for substrate and inhibitor selectivity. Chem. Biol. 7:2000;423-432
30. Suzuki Y., Nakabayashi Y., Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in fas-induced cell death. Proc. Nat. Acad. Sci. U. S. A. 98:2001;8662-8667
31. Richter B.W., Duckett C.S. The IAP proteins, caspase inhibitors and beyond. Sci. STKE. 44:2000;PE1
32. Hartmann-Petersen R., Seeger M., Gordon C. Transferring substrates to the 26S proteasome. Trends Biochem. Sci. 1:2003;26-31
33. Boyd J., Sonoda Y., Federici M.G., Bogomolniy F., Rhei E., Maresco D.L., Saigo P.E., Almadrones L.A., Barakat R.R., Brown C.L., Chi D.S., Curtin J.P., Poynor E.A., Hoskins W.J. Clinicopathological features of BRCA-linked and sporadic ovarian cancer. JAMA. 283:2000;2260-2265